Table 1 Patient characteristics at baseline (n = 66).
Characteristics | Overall (No.%) |
|---|---|
Gender, n (%) | |
Female | 37 (56.1%) |
Male | 29 (43.9%) |
Age, n (%) | |
≤ 60 | 34 (51.5%) |
> 60 | 32 (48.5%) |
Primary site, n (%) | |
Rectum | 49 (74.2%) |
Colon | 17 (25.8%) |
BMI, n (%) | |
Abnormal | 33 (50%) |
Normal | 33 (50%) |
R0 resection, n (%) | |
Yes | 65 (98.5%) |
No | 1 (1.5%) |
Max diameter of tumor(cm), median (IQR) | 3.5 (3, 4.5) |
Ratio of metastatic lymph nodes, median (IQR) | 0.11438 (0.076923, 0.17402) |
Pathological type, n (%) | |
Middle differentiated carcinoma | 57 (86.4%) |
Signet-ring cell carcinoma | 2 (3%) |
Well differentiated carcinoma | 3 (4.5%) |
Poorly differentiated carcinoma | 4 (6.1%) |
Total retrieved lymph nodes, n (%) | |
< 12 | 29 (43.9%) |
≥ 12 | 37 (56.1%) |
Number of metastatic lymph nodes, n (%) | |
1 | 38 (57.6%) |
2 | 20 (30.3%) |
3 | 8 (12.1%) |
Postoperative adjuvant chemotherapy, n (%) | |
Yes | 44 (66.7%) |
No | 22 (33.3%) |
CEA(ng/ml), median (IQR) | 2.27 (1.57, 6.215) |
CA199(U/ml), median (IQR) | 12.15 (7.155, 24.88) |
MPO(%), median (IQR) | 2.1245 (1.0935, 6.791) |
CD8T (%), median (IQR) | 3.1565 (1.113, 7.596) |
Treg (%), median (IQR) | 2.356 (0.9995, 6.324) |
PD-1 + CD8T (%), median (IQR) | 4.543 (0.93175, 8.3685) |
PD-1 + Treg (%), median (IQR) | 0.569 (0.08675, 1.4763) |
